Family donor transplant offers new hope for tough cancers

NCT ID NCT01804634

Summary

This study is testing a bone marrow transplant from a partially matched family donor (like a parent or sibling) for patients with advanced solid tumors that have not responded to other treatments. The goal is to use the donor's immune cells to fight the cancer while using a less intense chemotherapy regimen and a shorter course of immune-suppressing drugs to reduce side effects. Researchers aim to see if this approach is safe and can help control the disease in patients with very poor prognoses.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REFRACTORY AND/OR RELAPSED METASTATIC SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Albert Einstein College of Medicine, Children's Hospital at Montefiore

    RECRUITING

    The Bronx, New York, 10467, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • New York Medical Center/ Maria Fareri Children's Hospital

    RECRUITING

    Valhalla, New York, 10595, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21231, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.